SCHEMBL31246006

SCHEMBL31246006

CN1CCN(CCCNC(=O)c2cc(C(=O)O)cc(C(=O)O)c2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.63
▸ RAD52 P43351 1/20 0.57
▸ ALDH1A1 P00352 4/20 0.57
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ LMNA P02545 2/20 0.57
▸ GAA P10253 2/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ SLC29A1 Q99808 1/20 0.56
▸ HDAC2 Q92769 1/20 0.55
▸ HDAC8 Q9BY41 1/20 0.55
▸ HDAC6 Q9UBN7 1/20 0.55
▸ DRD2 P14416 1/20 0.53
▸ KDM4E B2RXH2 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ GLA P06280 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ KMT2A Q03164 2/20 0.50
▸ POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31245936 0.87 MAPT (0.61) MAPTRAD52ALDH1A1SMN1; SMN2LMNA
SCHEMBL31245846 0.86 MAPT (0.67) MAPTRAD52ALDH1A1SMN1; SMN2LMNA
SCHEMBL28240023 0.84 MAPT (0.61) MAPTRAD52ALDH1A1SMN1; SMN2LMNA
SCHEMBL16227646 0.84 ALDH1A1 (0.69) MAPTALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL31245956 0.81 MAPT (0.57) MAPTRAD52ALDH1A1SMN1; SMN2LMNA
SCHEMBL178534 0.80 KMT2A (0.71) MAPTRAD52ALDH1A1SMN1; SMN2LMNA
SCHEMBL17599747 0.79 ALDH1A1 (0.63) MAPTRAD52ALDH1A1SMN1; SMN2LMNA
SCHEMBL2949573 0.79 RAD52 (0.61) MAPTRAD52ALDH1A1SMN1; SMN2LMNA
SCHEMBL178368 0.79 HSD17B10 (0.64) MAPTRAD52ALDH1A1SMN1; SMN2LMNA
SCHEMBL19226707 0.78 SMN1; SMN2 (0.92) MAPTRAD52ALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 — — EP disclosed
WO-2024211865-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY OMEGA THERAPEUTICS, INC. (US) 2024-10-10 — — WO disclosed
Send feedback